ACB (Aurora Cannabis Inc. Common Shares) Stock Analysis - Analyst Ratings

Aurora Cannabis Inc. Common Shares (ACB) is a publicly traded Healthcare sector company. As of May 21, 2026, ACB trades at $3.48 with a market cap of $193.94M and a P/E ratio of 0.00. ACB moved +5.30% today. Year to date, ACB is -18.93%; over the trailing twelve months it is -35.02%. Its 52-week range spans $3.07 to $6.91. Rallies surfaces ACB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate ACB?

The average price target is $0.00.

ACB Key Metrics

Key financial metrics for ACB
MetricValue
Price$3.48
Market Cap$193.94M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.16%
52-Week High$6.91
52-Week Low$3.07
Volume2.16K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

ACB Analyst Consensus

ACB analyst coverage data. Average price target: $0.00.

Latest ACB News

Common questions about ACB

What do analysts rate ACB?
The average price target is $0.00.
Does Rallies show ACB price targets?
Yes. Rallies tracks ACB analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is ACB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ACB. It does not provide personalized investment advice.
ACB

ACB